Artivion News

Analysts' Opinions Are Mixed on These Healthcare Stocks: CVS Health (CVS), Insulet (PODD) and Artivion (AORT)

TipRanksAug 9 09:09 ET

Oppenheimer Reaffirms Their Buy Rating on Artivion (AORT)

TipRanksAug 9 09:08 ET

Artivion Analyst Ratings

BenzingaAug 9 08:27 ET

Oppenheimer Adjusts Artivion Price Target to $30 From $25, Maintains Outperform Rating

MT NewswiresAug 9 08:24 ET

Artivion's Robust Financial Performance and Growth Prospects Justify Buy Rating

TipRanksAug 9 08:15 ET

Lake Street Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsAug 6 09:34 ET

Lake Street Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsAug 5 09:33 ET

Lake Street Sticks to Their Buy Rating for Artivion (AORT)

TipRanksAug 5 09:01 ET

Artivion Analyst Ratings

BenzingaJul 2 10:10 ET

Artivion's Strong Market Position and Revised Endospan Deal Justify a Buy Rating and Increased Price Target

TipRanksJul 2 09:06 ET

Oppenheimer Sticks to Its Buy Rating for Artivion (AORT)

TipRanksMay 7 08:20 ET

Artivion: Strong Q1 Performance and Raised Guidance Validate Buy Rating

TipRanksMay 7 07:46 ET

Artivion Analyst Ratings

BenzingaMay 7 05:56 ET

Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Axonics Modulation Technologies (AXNX) and Artivion (AORT)

TipRanksMay 6 09:05 ET

Artivion Analyst Ratings

BenzingaApr 8 14:36 ET

Artivion's Growth Trajectory: A Buy Rating Amidst Promising Aortic Products and Financial Upswing

TipRanksApr 8 14:20 ET

Stifel Nicolaus Remains a Buy on Artivion (AORT)

TipRanksFeb 16 08:08 ET

Oppenheimer Sticks to Its Buy Rating for Artivion (AORT)

TipRanksFeb 16 07:56 ET

Artivion Secures Buy Rating: Strong Financials and Growth Trajectory Propel Price Target Increase

TipRanksFeb 16 05:56 ET

Artivion Analyst Ratings

BenzingaFeb 16 05:43 ET